Profiling of differentially expressed proteins in stage IV Colorectal cancers with good and poor outcomes

Hye Jung Kim, Un Beom Kang, Hanna Lee, Ji Han Jung, Seung Taek Lee, Myeong Hee Yu, Hoguen Kim, Cheolju Lee

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)


Screening patients at high risk of recurrence of cancer would allow for more accurate and personalized treatment. In this study, we tried to identify the prognosis-related protein profile by applying two different quantitative proteomic techniques, difference in-gel electrophoresis and cleavable isotope-coded affinity tag method. Six tumor tissues were obtained from stage IV colorectal cancer (CRC) patients, of which three have survived more than five years (good prognostic group, GPG) and the other three died within 25. months (poor prognostic group, PPG) after palliative surgery and subsequent chemotherapy treatment. From the two independent quantitative analyses, we identified 175 proteins with abundance ratios greater than 2-fold. Gene ontology analysis revealed that proteins related to cellular assembly/organization and movement were generally increased in the PPG. Twenty-two proteins, including caveolin-1, were chosen for confirmatory studies by Western blot and immunohistochemistry. The Western blot data for each individual protein were analyzed with Mann-Whitney tests, and a multi-marker panel was generated by logistic regression analysis. Five proteins, fatty acid binding protein 1, intelectin 1, transitional endoplasmic reticulum ATPase, transgelin and tropomyosin 2, were significantly different between the two prognostic groups within 95% confidence. No single protein could completely distinguish the two groups from each other. However, a combination of the five proteins effectively distinguished PPG from GPG patients (AUC = 1). Our study suggests a multi-marker panel composed of proteome signatures that provide accurate predictive information and potentially assist personalized therapy. This article is part of a Special Issue entitled: Proteomics: The clinical link.

Original languageEnglish
Pages (from-to)2983-2997
Number of pages15
JournalJournal of Proteomics
Issue number10
Publication statusPublished - 2012 Jun 6

Bibliographical note

Funding Information:
This research was supported by grants from the 21C Frontier Functional Proteomics Project funded by the Korean Ministry of Science & Technology .

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry


Dive into the research topics of 'Profiling of differentially expressed proteins in stage IV Colorectal cancers with good and poor outcomes'. Together they form a unique fingerprint.

Cite this